Assessment of plasma prothrombotic factors in patients with Buerger's disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Blood Coagulation and Fibrinolysis

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MBC.0b013e32835b7272PMID 23358197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations.

  2009cited by this paper
• Cobalamin, folic acid, and homocysteine.

  2009cited by this paper
• Prävalenz der Hyperhomocysteinämie bei der Thrombangiitis obliterans: Spielt Homocystein pathogenetisch eine Rolle?

  2008cited by this paper
• Thromboangiitis obliterans (Buerger's disease)

  2006cited by this paper
• Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction

  2003cited by this paper
• [A new thrombophilia risk factor: the increase of plasma factor VIII].

  2003cited by this paper
• [High levels of factor VIIIc and risk of venous thrombosis: critical analysis of case-control studies].

  2003cited by this paper
• Élévation du facteur VIIIc coagulant et risque de thrombose veineuse : analyse critique des études cas–témoins

  2003cited by this paper
• Buerger's disease in the 21st century: diagnosis, clinical features, and therapy.

  2003cited by this paper
• Association Between Increased Homocysteine Levels and Impaired Fibrinolytic Potential: Potential Mechanism for Cardiovascular Risk

  2002cited by this paper
• Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis?

  2001cited by this paper
• Homocysteine and atherothrombosis

  2001cited by this paper
• Thromboangiitis obliterans (Buerger's disease).

  2001cited by this paper
• Prothrombin Gene 20210 G→A and Factor V Arg 506 to Gln Mutation in a Patient with Buerger's Disease

  2000cited by this paper
• High levels of coagulation factor XI as a risk factor for venous thrombosis.

  2000cited by this paper
• Three cases of Buerger's disease associated with hyperhomocysteinemia.

  2000cited by this paper
• Prevalence and significance of thrombophilia in patients with intermittent claudication

  1999cited by this paper
• Vascular surgical society of great britain and ireland: prevalence and significance of thrombophilia in patients with intermittent claudication

  1999cited by this paper
• Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.

  1999cited by this paper
• A Case of Buerger’s Disease Associated with High Levels of Lipoprotein(a)

  1999cited by this paper
• Screening for Aetiology of Thrombophilia: A High Prevalence of Protein S Abnormality

  1999cited by this paper
• High early mortality rate from acute pancreatitis in Scotland, 1984–1995

  1999cited by this paper
• UROKINASE PLASMINOGEN ACTIVATOR SYSTEM IN HUMANS WITH STABLE CORONARY ARTERY DISEASE

  1999cited by this paper
• Homocysteine and atherothrombosis.

  1998cited by this paper
• Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells.

  1998cited by this paper
• Pathogenesis of Vascular Disease in Hyperhomocysteinaemia

  1998cited by this paper
• Fibrinogen as a risk factor for coronary heart disease.

  1998cited by this paper
• Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL‐4, IL‐10 and IL‐13: consequences on cell adhesion to vitronectin and fibrinogen

  1998cited by this paper
• Diagnostic criteria of Buerger's disease.

  1998cited by this paper
• Acute hyperhomocysteinaemia and endothelial dysfunction.

  1998cited by this paper
• Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

  1997cited by this paper
• Homocysteine and thrombotic disease.

  1997cited by this paper
• Antithrombin and its inherited deficiency states.

  1997cited by this paper
• Coagulation factor VII and the risk of coronary heart disease in healthy men.

  1997cited by this paper
• Thromboangiitis Obliterans (Buerger's Disease)

  1997cited by this paper
• Antithrombin and its inherited deficiency states.

  1997cited by this paper
• Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

  1996cited by this paper
• Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.

  1996cited by this paper
• Activated protein C resistance: prevalence and implications in peripheral vascular disease.

  1996cited by this paper
• Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells.

  1996cited by this paper
• [Pseudothromboangiitis obliterans and qualitative protein C deficiency: report of a case].

  1996cited by this paper
• [The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically?].

  1996cited by this paper
• Plasminogen activators and plasminogen activator inhibitor 1 before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger's disease).

  1992cited by this paper
• Immunological studies on thromboangiitis obliterans.

  1989cited by this paper
• Studies on hypercoagulation state in thromboangiitis obliterans.

  1989cited by this paper
• Pathogenetic key position of thromboangitis: the endothelial cell. Serum dependent proliferation studies of endothelial cells in obliterative angiopathies.

  1986cited by this paper
• Vascular surgical society of Great Britain and Ireland

  1986cited by this paper

• The Angiography Pattern of Buerger’s Disease: Challenges and Recommendations

  2025cites this paper
• Exploring the oxidative and inflammatory markers landscape in Buerger’s disease: A comparative analysis

  2025cites this paper
• A Meta-Analysis of Plasma Homocysteine in Buerger's Disease.

  2022cites this paper
• Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical Consequences

  2021cites this paper
• Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review

  2019cites this paper
• Lesiones necróticas en las manos: enfermedad de Buerger

  2017cites this paper
• The role of apolipoprotein (a) in pathogenesis and clinical course of deep venous thrombosis.

  2015cites this paper
• Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans.

  2015cites this paper
• The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (Thromboangiitis Obliterans)

  2014cites this paper
• Hemophilic synovitis of the knee: radiosynovectomy or arthroscopic synovectomy?

  2014cites this paper
• [What's new in internal medicine?].

  2013cites this paper
• Manejo anestésico de un paciente hemofílico con trombofilia

  2011cites this paper